Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2259

    2.

    Age-dependent changes in breast cancer hormone receptors and oxidant stress markers.

    Quong J, Eppenberger-Castori S, Moore D 3rd, Scott GK, Birrer MJ, Kueng W, Eppenberger U, Benz CC.

    Breast Cancer Res Treat. 2002 Dec;76(3):221-36.

    PMID:
    12462383
    [PubMed - indexed for MEDLINE]
    3.

    Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.

    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.

    Anticancer Res. 2006 May-Jun;26(3A):1773-84.

    PMID:
    16827106
    [PubMed - indexed for MEDLINE]
    4.

    Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

    Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.

    J Clin Oncol. 2006 Apr 10;24(11):1656-64. Epub 2006 Feb 27.

    PMID:
    16505416
    [PubMed - indexed for MEDLINE]
    5.

    Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.

    Kim HJ, Cui X, Hilsenbeck SG, Lee AV.

    Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1013s-1018s.

    PMID:
    16467118
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.

    PMID:
    17850661
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.

    Osborne JR, Port E, Gonen M, Doane A, Yeung H, Gerald W, Cook JB, Larson S.

    J Nucl Med. 2010 Apr;51(4):543-50. Epub 2010 Mar 17.

    PMID:
    20237034
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

    Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.

    PMID:
    17671124
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

    Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ.

    J Natl Cancer Inst. 2003 Jan 15;95(2):142-53.

    PMID:
    12529347
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.

    Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB.

    Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3478-84.

    PMID:
    16740773
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.

    Jacobsen BM, Schittone SA, Richer JK, Horwitz KB.

    Mol Endocrinol. 2005 Mar;19(3):574-87. Epub 2004 Nov 24.

    PMID:
    15563544
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

    Breast Cancer Res Treat. 2009 Jul;116(1):131-43. Epub 2008 Jul 31.

    PMID:
    18668363
    [PubMed - indexed for MEDLINE]
    13.

    Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.

    Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET.

    Breast Cancer Res. 2007;9(2):R25.

    PMID:
    17428314
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.

    Harigopal M, Heymann J, Ghosh S, Anagnostou V, Camp RL, Rimm DL.

    Breast Cancer Res Treat. 2009 May;115(1):77-85. Epub 2008 Jun 3.

    PMID:
    18521745
    [PubMed - indexed for MEDLINE]
    15.

    Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

    J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.

    PMID:
    16145046
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.

    Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H, Blomqvist C.

    Breast Cancer Res Treat. 2009 Jan;113(1):75-82. Epub 2008 Feb 1.

    PMID:
    18240019
    [PubMed - indexed for MEDLINE]
    18.

    T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

    Breast Cancer Res. 2009;11(2):R15. Epub 2009 Mar 9.

    PMID:
    19272155
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.

    Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M, Kage M.

    Cancer Res. 2008 Mar 1;68(5):1504-12.

    PMID:
    18316615
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

    Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

    PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.

    PMID:
    19270750
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk